BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33315302)

  • 21. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 22. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome Editing: CRISPR-Cas9.
    Hoof JB; Nødvig CS; Mortensen UH
    Methods Mol Biol; 2018; 1775():119-132. PubMed ID: 29876814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
    Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
    Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generating Mutant for a Stress-Responsive Gene in Rice Using CRISPR-Cas9 System.
    Prakash CS; Sunkar R
    Methods Mol Biol; 2024; 2832():281-290. PubMed ID: 38869803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Agrobacterium-Mediated CRISPR/Cas9 Platform for Genome Editing in Maize.
    Lee K; Zhu H; Yang B; Wang K
    Methods Mol Biol; 2019; 1917():121-143. PubMed ID: 30610633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects.
    Paul JW; Qi Y
    Plant Cell Rep; 2016 Jul; 35(7):1417-27. PubMed ID: 27114166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
    Wardyn JD; Chan ASY; Jeyasekharan AD
    Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Based Gene Editing in Soybean.
    Bao A; Tran LP; Cao D
    Methods Mol Biol; 2020; 2107():349-364. PubMed ID: 31893458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular tools for gene manipulation in filamentous fungi.
    Wang S; Chen H; Tang X; Zhang H; Chen W; Chen YQ
    Appl Microbiol Biotechnol; 2017 Nov; 101(22):8063-8075. PubMed ID: 28965220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9-Based Gene Dropout Screens.
    Wu K; Malek SN
    Methods Mol Biol; 2019; 1881():185-200. PubMed ID: 30350207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted mutagenesis in cotton (Gossypium hirsutum L.) using the CRISPR/Cas9 system.
    Chen X; Lu X; Shu N; Wang S; Wang J; Wang D; Guo L; Ye W
    Sci Rep; 2017 Mar; 7():44304. PubMed ID: 28287154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering.
    Arazoe T; Kondo A; Nishida K
    Biotechnol J; 2018 Sep; 13(9):e1700596. PubMed ID: 29862665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
    Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
    BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia.
    Gago S; Overton NLD; Bowyer P
    Methods Mol Biol; 2021; 2260():37-47. PubMed ID: 33405030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.